Virtus LifeSci Biotech Clinical Tri... (BBC)
$24.4486
+0.13 (+0.55%)
Rating:
Recommendation:
-
| Symbol | BBC |
|---|---|
| Price | $24.4486 |
| Beta | 0.000 |
| Volume Avg. | 0.00M |
| Market Cap | - |
| Shares () | - |
| 52 Week Range | 17.77-40.86 |
| 1y Target Est | - |
| DCF Unlevered | BBC DCF -> | |
|---|---|---|
| DCF Levered | BBC LDCF -> | |
| ROE | - | |
| ROA | - | |
| Operating Margin | - | |
| Debt / Equity | - | |
| P/E | - | |
| P/B | - |
Latest BBC news
About
Download (Excel)Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.